There is a difference between breast cancer awareness… and metastatic breast cancer reality.
For years, the world has been wrapped in pink ribbons, survivor stories, and celebration walks. And that matters.
But metastatic — Stage 4 — is different.
Metastatic breast cancer is not a finish line story.
It is not a “ring the bell and move on” chapter.
It is ongoing treatment. Ongoing scans. Ongoing uncertainty.
It is living with cancer, not past it.
And that’s exactly why metastatic matters.
The Reality in Numbers
Metastatic breast cancer is the only stage considered incurable.
-
About 6–10% of people are diagnosed at Stage 4 from the start (called de novo metastatic).
-
An estimated 20–30% of those initially diagnosed with early-stage breast cancer will eventually develop metastatic disease.
-
In North America, the 5-year survival rate for metastatic breast cancer is around 30% — meaning it is still classified as a life-limiting illness.
-
In the United States alone, over 40,000 people die from breast cancer each year — and the vast majority of those deaths are due to metastatic disease.
These aren’t small numbers.
These are Mothers. Daughters. Friends. Creators. Caregivers.
These are people living in treatment cycles for the rest of their lives.
The Invisible Gap
Despite this, metastatic breast cancer receives a disproportionately small percentage of overall breast cancer research funding.
The public narrative often focuses on survivorship.
But survivorship is not the whole story.
There is an entire community living scan to scan, infusion to infusion — navigating hope and realism in the same breath.
When metastatic isn’t visible:
-
It’s misunderstood.
-
It’s minimized.
-
It’s underfunded.
And when something is underfunded, progress slows.
Why Visibility Saves Lives
When metastatic is visible:
Research funding grows.
Clinical trials expand.
Early detection awareness deepens.
Treatment options improve.
Visibility drives conversation.
Conversation drives funding.
Funding drives research.
Research extends lives.
This isn’t abstract.
This is measurable.
Wearing the Truth
That’s why I create metastatic designs.
That’s why I use pink, teal, and green.
That’s why I say “Cancer Sucks” without softening it.
It’s not about negativity.
It’s about clarity.
Every time someone wears metastatic colors, they are saying:
We are here.
We matter.
We deserve research.
We deserve better outcomes.
And when we are seen, we are harder to ignore.
Make Metastatic Visible
Metastatic breast cancer is not rare.
It is not a footnote in the breast cancer story.
It is the reason most people die from breast cancer.
And yet, many people don’t know the metastatic colors.
Many don’t know that Stage 4 is incurable.
Many don’t know that thousands of people are living in ongoing treatment every day.
That’s why visibility matters.
When we talk about metastatic disease, we change the conversation.
When we wear the colors, we start new ones.
When we share information, we push research forward.
If this article taught you something new, consider sharing it with someone else.
Because metastatic matters.
And visibility saves lives.
If you’d like to help make Stage 4 more visible, you can check out the Metastatic 4 Star shirt here:
Sources
-
American Cancer Society (ACS) – Breast Cancer Facts & Figures
-
Statistics on Stage 4 diagnosis rates and 5-year survival
-
Annual U.S. breast cancer mortality data
www.cancer.org
-
-
National Cancer Institute (NCI) – Surveillance, Epidemiology, and End Results (SEER) Program
-
Survival rates for metastatic (Stage 4) breast cancer
-
Long-term outcome data
www.cancer.gov
-
-
Breastcancer.org
-
Data on recurrence rates (20–30% of early-stage cases progressing to metastatic disease)
-
Patient-centered explanations of metastatic breast cancer
www.breastcancer.org
-
-
Metastatic Breast Cancer Alliance (MBCA)
-
Research funding gaps
-
Reports on metastatic-specific advocacy and unmet needs
www.mbcalliance.org
-
